Product Details
Formula
C36H38F4N4O2S
MW
666.78
Purity
>95%
Solubility (DMSO Mg/MI)
90
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Discontinued in Phase 2
Target Name
Phospholipase A2 (PLA2G1B)
Research Area
CARDIOVASCULAR
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Phospholipase
Bio Chemical Notes
Darapladib (SB-480848) is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM